Your browser doesn't support javascript.
loading
In pursuit of a minimal CHO genome: Establishment of large-scale genome deletions.
Jerabek, Tobias; Weiß, Linus; Fahrion, Hannah; Zeh, Nikolas; Raab, Nadja; Lindner, Benjamin; Fischer, Simon; Otte, Kerstin.
Afiliação
  • Jerabek T; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany. Electronic address: jerabek@hochschule-bc.de.
  • Weiß L; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany.
  • Fahrion H; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany.
  • Zeh N; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany; Boehringer Ingelheim Pharma GmbH & Co KG, Bioprocess Development Biologicals, Cell Line Development, Biberach, Germany.
  • Raab N; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany.
  • Lindner B; Boehringer Ingelheim Pharma GmbH & Co KG, Bioprocess Development Biologicals, Cell Line Development, Biberach, Germany.
  • Fischer S; Boehringer Ingelheim Pharma GmbH & Co KG, Bioprocess Development Biologicals, Cell Line Development, Biberach, Germany.
  • Otte K; University of Applied Sciences Biberach, Institute of Applied Biotechnology, Biberach, Germany.
N Biotechnol ; 79: 100-110, 2024 Mar 25.
Article em En | MEDLINE | ID: mdl-38154614
ABSTRACT
Chinese hamster ovary (CHO) cells are the most commonly used mammalian cell line for the production of complex therapeutic glycoproteins. As CHO cells have evolved as part of a multicellular organism, they harbor many cellular functions irrelevant for their application as production hosts in industrial bioprocesses. Consequently, CHO cells have been the target for numerous genetic engineering efforts in the past, but a tailored host cell chassis holistically optimized for its specific task in a bioreactor is still missing. While the concept of genome reduction has already been successfully applied to bacterial production cells, attempts to create higher eukaryotic production hosts exhibiting reduced genomes have not been reported yet. Here, we present the establishment and application of a large-scale genome deletion strategy for targeted excision of large genomic regions in CHO cells. We demonstrate the feasibility of genome reduction in CHO cells using optimized CRISPR/Cas9 based experimental protocols targeting large non-essential genomic regions with high efficiency. Achieved genome deletions of non-essential genetic regions did not introduce negative effects on bioprocess relevant parameters, although we conducted the largest reported genomic excision of 864 kilobase pairs in CHO cells so far. The concept presented serves as a directive to accelerate the development of a significantly genome-reduced CHO host cell chassis paving the way for a next generation of CHO cell factories.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia Genética / Genoma Limite: Animals Idioma: En Revista: N Biotechnol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Engenharia Genética / Genoma Limite: Animals Idioma: En Revista: N Biotechnol Ano de publicação: 2024 Tipo de documento: Article